266 related articles for article (PubMed ID: 14974118)
21. Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency).
Carchon H; Van Schaftingen E; Matthijs G; Jaeken J
Biochim Biophys Acta; 1999 Oct; 1455(2-3):155-65. PubMed ID: 10571009
[TBL] [Abstract][Full Text] [Related]
22. Identification of a IVS4-58delATG polymorphism in the human phosphomannomutase 2 (PMM2) gene.
Vuillaumier-Barrot S; Bizec CL; Durand G; Grandchamp B; Seta N
Hum Mutat; 2000 May; 15(5):486. PubMed ID: 10790224
[No Abstract] [Full Text] [Related]
23. A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies.
Zhang W; James PM; Ng BG; Li X; Xia B; Rong J; Asif G; Raymond K; Jones MA; Hegde M; Ju T; Cummings RD; Clarkson K; Wood T; Boerkoel CF; Freeze HH; He M
Clin Chem; 2016 Jan; 62(1):208-17. PubMed ID: 26430078
[TBL] [Abstract][Full Text] [Related]
24. Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I.
Callewaert N; Schollen E; Vanhecke A; Jaeken J; Matthijs G; Contreras R
Glycobiology; 2003 May; 13(5):367-75. PubMed ID: 12626389
[TBL] [Abstract][Full Text] [Related]
25. Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts.
Eklund EA; Merbouh N; Ichikawa M; Nishikawa A; Clima JM; Dorman JA; Norberg T; Freeze HH
Glycobiology; 2005 Nov; 15(11):1084-93. PubMed ID: 16079417
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of congenital disorders of glycosylation type-I using protein chip technology.
Mills K; Mills P; Jackson M; Worthington V; Beesley C; Mann A; Clayton P; Grunewald S; Keir G; Young L; Langridge J; Mian N; Winchester B
Proteomics; 2006 Apr; 6(7):2295-304. PubMed ID: 16552784
[TBL] [Abstract][Full Text] [Related]
27. The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia).
Grünewald S
Biochim Biophys Acta; 2009 Sep; 1792(9):827-34. PubMed ID: 19272306
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal and other clinical manifestations in 17 children with congenital disorders of glycosylation type Ia, Ib, and Ic.
Damen G; de Klerk H; Huijmans J; den Hollander J; Sinaasappel M
J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):282-7. PubMed ID: 15076627
[TBL] [Abstract][Full Text] [Related]
29. Mass spectrometry for congenital disorders of glycosylation, CDG.
Wada Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):3-8. PubMed ID: 16517226
[TBL] [Abstract][Full Text] [Related]
30. Functional analysis of three splicing mutations identified in the PMM2 gene: toward a new therapy for congenital disorder of glycosylation type Ia.
Vega AI; Pérez-Cerdá C; Desviat LR; Matthijs G; Ugarte M; Pérez B
Hum Mutat; 2009 May; 30(5):795-803. PubMed ID: 19235233
[TBL] [Abstract][Full Text] [Related]
31. Screening and diagnosis of congenital disorders of glycosylation.
Marklová E; Albahri Z
Clin Chim Acta; 2007 Oct; 385(1-2):6-20. PubMed ID: 17716641
[TBL] [Abstract][Full Text] [Related]
32. Phosphomannomutase activity in congenital disorders of glycosylation type Ia determined by direct analysis of the interconversion of mannose-1-phosphate to mannose-6-phosphate by high-pH anion-exchange chromatography with pulsed amperometric detection.
Orvisky E; Stubblefield B; Long RT; Martin BM; Sidransky E; Krasnewich D
Anal Biochem; 2003 Jun; 317(1):12-8. PubMed ID: 12729595
[TBL] [Abstract][Full Text] [Related]
33. Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik.
Grubenmann CE; Frank CG; Hülsmeier AJ; Schollen E; Matthijs G; Mayatepek E; Berger EG; Aebi M; Hennet T
Hum Mol Genet; 2004 Mar; 13(5):535-42. PubMed ID: 14709599
[TBL] [Abstract][Full Text] [Related]
34. Congenital disorder of glycosylation type Ia presenting with hydrops fetalis.
van de Kamp JM; Lefeber DJ; Ruijter GJ; Steggerda SJ; den Hollander NS; Willems SM; Matthijs G; Poorthuis BJ; Wevers RA
J Med Genet; 2007 Apr; 44(4):277-80. PubMed ID: 17158594
[TBL] [Abstract][Full Text] [Related]
35. Targeted disruption of the mouse phosphomannomutase 2 gene causes early embryonic lethality.
Thiel C; Lübke T; Matthijs G; von Figura K; Körner C
Mol Cell Biol; 2006 Aug; 26(15):5615-20. PubMed ID: 16847317
[TBL] [Abstract][Full Text] [Related]
36. Congenital disorder of glycosylation type Ia in a 6-year-old girl with a mild intellectual phenotype: two novel PMM2 mutations.
Coman D; Klingberg S; Morris D; McGill J; Mercer H
J Inherit Metab Dis; 2005; 28(6):1189-90. PubMed ID: 16435227
[TBL] [Abstract][Full Text] [Related]
37. Mass spectrometry in the characterization of human genetic N-glycosylation defects.
Barone R; Sturiale L; Garozzo D
Mass Spectrom Rev; 2009; 28(3):517-42. PubMed ID: 18844296
[TBL] [Abstract][Full Text] [Related]
38. Severe ALG8-CDG (CDG-Ih) associated with homozygosity for two novel missense mutations detected by exome sequencing of candidate genes.
Sorte H; Mørkrid L; Rødningen O; Kulseth MA; Stray-Pedersen A; Matthijs G; Race V; Houge G; Fiskerstrand T; Bjurulf B; Lyle R; Prescott T
Eur J Med Genet; 2012 Mar; 55(3):196-202. PubMed ID: 22306853
[TBL] [Abstract][Full Text] [Related]
39. Quality control of glycoproteins bearing truncated glycans in an ALG9-defective (CDG-IL) patient.
Vleugels W; Keldermans L; Jaeken J; Butters TD; Michalski JC; Matthijs G; Foulquier F
Glycobiology; 2009 Aug; 19(8):910-7. PubMed ID: 19451548
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of phosphomannose isomerase by fructose 1-phosphate: an explanation for defective N-glycosylation in hereditary fructose intolerance.
Jaeken J; Pirard M; Adamowicz M; Pronicka E; van Schaftingen E
Pediatr Res; 1996 Nov; 40(5):764-6. PubMed ID: 8910943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
